Claim OwnershipeanCast: Weekly Neurology
Subscribed: 46Played: 721
Subscribe
© 2022 ean.org
Description
eanCast: Weekly Neurology is your source for education, research and updates from the European Academy of Neurology. Regardless of experience level, you are invited to join expert moderators and guests in reviewing, discussing, and debating various topics within the 29 EAN sub-specialties.
New neurological topics every month, and new episodes every Monday.
New neurological topics every month, and new episodes every Monday.
104 Episodes
Reverse
Moderator: Anne Pavy-Le Traon (Toulouse, France)Guests: Diogo Carneiro (Coimbra, Portugal); Fabian Leys (Innsbruck, Austria)In this episode, Anne Pavy-Le Traon talks with Diogo Carneiro and Fabian Leys about the Post-Covid Autonomic Dysfunction, a disease that appeared during the recent COVID-19 pandemics but is still present in a large number of individuals. They highlight the syndromic constellation of this entity which affects different body organs and the general principles of its management.
Release Date: 24.06.2024Moderator: Barbara Tettenborn (St. Gallen, Switzerland)Guest: Marian Galovic (Zurich, Switzerland)In this episode Barbara Tettenborn talks with Dr. Marian Galovic about acute symptomatic seizures, a frequent but commonly misunderstood topic. They highlight the impact of acute symptomatic seizures on outcomes and brain health, their implications for developing epilepsy and the resulting treatment considerations.
Moderator: Andrew Chan (Bern, Switzerland)Guests: Barbara Kornek (Vienna, Austria) and Fredrik Sandesjo (Stockholm, Sweden)Pediatric onset multiple sclerosis (POMS) is increasingly recognized as a non-benign condition which requires consequent disease modifying treatment. In this special episode Andrew Chan hosts Barbara Kornek and Fredrik Sandesjö. They discuss epidemiological, biological and clinical characteristics of POMS, and highlight early highly effective therapy in this vulnerable patient group and the treatment in POMS.
Moderator: Barbara Tettenborn (St. Gallen, Switzerland)Guests: Claudio Bassetti (Bern, Switzerland) and Elena Moro (Grenoble, France)We are thrilled to announce a milestone celebration: the 100th episode of eanCast!In this special episode, we are honoured to welcome two distinguished guests. The past president of EAN, Prof. Claudio Bassetti, who will share insights into the challenges faced and achievements accomplished during his tenure, along with exciting projects that have made a lasting impact. Additionally, we will be joined by the first female future president of EAN: Prof. Elena Moro, who will discuss her vision and plans for her upcoming presidency.
Moderator: Barbara Tettenborn (St. Gallen, Switzerland)Guest: Jutta Keller (Hamburg, Germany)In this episode of eanCast and UEG Talks, host Prof. Barbara Tettenborn from the EAN and guest Prof. Jutta Keller from UEG discuss neuro-gastroenterology, focusing on the gut-brain axis and its implications for various gastrointestinal and neurological disorders. They explore the influence of the microbiome on gut function, the impact of diet on brain health, and strategies for managing gastrointestinal symptoms in patients with neurological conditions like Parkinson's disease.United European Gastroenterology (UEG) is a strategic partner of the Brain Health Mission (BHM). This episode is brought to you by the Brain Health Mission.
Moderator: Alicia Gonzalez (Madrid, Spain)Guest: Christian Lampl (Linz, Austria)This last May episode features Alicia González Martínez and her guest Prof. Christian Lampl as they discuss organising headache care, focusing on increasing access and offering value-based healthcare. They delve into strategies to improve the delivery, efficiency, and cost-effectiveness of headache management, aiming to enhance patient well-being and integration of headache care into existing healthcare systems.
Moderator: Daniele Martinelli (Pavia, Italy)Guest: Raquel Gil-Gouveia (Oeiras, Portugal)Guest: Antoinette Maassen van den Brink (Rotterdam, The Netherlands)Join us in this episode as Daniele Martinelli engages in a dialogue with esteemed experts, Prof. Antoinette Maassen van den Brink and Dr. Raquel Gil-Gouveia.They delve into animal models—our window into the brain’s hidden mechanisms. These models reveal neurotransmitter dynamics and potential triggers, paving the way for novel therapies. Additionally, they explore gender-specific nuances, shaping the understanding and personalized management strategies. By bridging theory to practice, they emphasize collaboration—a path toward better patient outcomes, alleviating the burden of this debilitating condition.
Moderator: Anna Gryglas-Dworak (Wroclaw, Poland)Guest: Dimos-Dimitrios Mitsikostas (Athens, Greece)This podcast episode presents the current guidelines of the European Headache Federation (published in 2021, updated in 2022) and the American Headache Society (2024) on migraine treatment. Acute and preventive as well as new and old options are discussed.
Moderator: Bianca Raffaelli (Berlin, Germany)Guest: Messoud Ashina (Copenhagen, Denmark)Guest: Cristina Tassorelli (Pavia, Italy)In this episode, Bianca Raffaelli hosts experts Messoud Ashina and Cristina Tassorelli on how to navigate the newly enriched therapeutic armamentarium of migraine with disease-specific drugs for the prevention and the acute treatment of attacks. They delve into the questions how, when, where, who and for whom.
Moderator: Giovanni Palermo (Pisa, Italy)Guest: Sterre van der Veen (Groningen, The Netherlands)In this episode, Giovanni Palermo and Sterre van der Veen explore the myoclonus phenomenon from its semiology to treatment, while dissecting the complexity of classification systems aimed at recognising its nature and determining its underlying causes.
In this episode Iva Stankovic hosts Alessio Di Fonzo to discuss how to diagnose chorea and how to approach differential diagnosis to entangle the etiology of chorea.
Moderator: Yildiz Degirmenci (Istanbul, Turkey)Guest: Vladimira Vuletic (Rijeka, Croatia)In this episode Yildiz Degirmenci and Vladimira Vuletic cover the approach to dystonia emergencies. Dystonia, marked by muscle contractions and abnormal movements, can be triggered by medications like antipsychotics. Management includes stopping triggering drugs and using medications like diphenhydramine. Status dystonicus, a severe form, requires intensive care with oxygen or ventilation. Primary and secondary dystonias are prone to this condition, possibly needing medication adjustments or deep brain stimulation. They stress the significance of patient history for precise diagnosis and treatment.
Moderator: Yildiz Degirmenci (Istanbul, Turkey)Guest: Christos Ganos (Berlin, Germany)Yildiz Degirmenci hosts a discussion with Christos Ganos, a movement disorder specialist, about ticks and Tourette syndrome. They delve into the definition of ticks, discuss diagnostic criteria, and differentiate between primary and functional tic disorders. The conversation also covers treatment options, including psychoeducation, psychological interventions like cognitive behavioral therapy, pharmacological treatments such as antipsychotics, and invasive neuromodulation methods.
Moderator: Rolf Fronczek (Leiden, The Netherlands)Guest: Marina Tüzün (Bern, Switzerland)Rolf Fronczek and Marina Tüzün discuss the Burden of Sleep Disorders Project, targeting daytime sleepiness and insomnia across Europe. They emphasize primary care collaboration for effective management, including patient perspectives and long-term follow-ups. Dr. Tüzün's personal interest in sleep research drives her involvement, inviting listeners to stay updated on the project's progress.
Moderator: Francesco Di Lorenco (Rome, Italy)Guest: Dag Aarsland (London, United Kingdom)Francesco Di Lorenco and Prof. Dag Aarsland discuss managing behavioral symptoms in dementia, highlighting the burden on patients and families. They stress the importance of timely treatment and challenges in diagnosis. They mention brexpiprazole's FDA approval for Alzheimer's agitation and the need for careful monitoring. Early detection of psychiatric symptoms in neurological diseases is crucial, but distinguishing between disorders is challenging. Therapeutic options like clozapine and cholinesterase inhibitors are mentioned, calling for more research and collaboration.
Moderator: Massimo Filippi (Milan, Italy)Guest: Federica Agosta (Milan, Italy)In this week’s episode Prof. Massimo Filippi and Prof. Federica Agosta discuss frontotemporal dementia (FTD) emphasizing the role of neuroimaging (MRI and FDG PET) in early diagnosis. They highlight MRI for identifying crucial patterns and FDG PET for detecting metabolic changes. Early detection is crucial for future treatments. Connectomics, studying brain networks, aids in predicting FTD progression. Emerging PET tracers, like UCBJ, show promise for early neurodegeneration markers. The episode is a valuable resource for neurologists interested in FTD diagnostics and monitoring.
Moderator: Youssuf Saleh (Oxford, United Kingdom)Guest: Sebastiaan Engelborghs (Brussel, Belgium)Youssuf Saleh interviews Prof. Sebastiaan Engelborghs on Alzheimer's biomarkers, focusing on amyloid and tau. They discuss diagnostic challenges, the need for prognostic markers, and potential serum markers like neurofilament light. Engelborghs highlights Alzheimer's complexity and the role of omics studies in patient subpopulations. The interview concludes with optimism for blood-based biomarkers revolutionizing diagnosis in the next five years, contingent on clinical validation and evolving therapies.
Moderator: Svetlana Tomic (Osijek, Croatia)Guest: Veronica Cabreira (Edinburgh, United Kingdom)In this episode of eanCast, Prof. Svetlana Tomic and Dr. Veronica Cabreira delve into the definition functional cognitive impairment. This disorder, affecting a significant number of patients at memory clinics, is marked by severe attention and concentration issues, and excessive self-monitoring of cognitive performance. Diagnosis hinges on cognitive symptoms, distress, and internal inconsistency. Treatments range from explaining the diagnosis to cognitive restructuring, cognitive behavioral therapy, and managing comorbidities.
Moderator: Federica Montagnese (Munich, Germany)Guest: John Vissing (Copenhagen, Denmark)In this week's episode, Federica Montagnese hosts Professor John Vissing as they delve into the intricate world of diagnosing muscular dystrophies. The discussion revolves around the crucial role of neuromuscular examinations and the significance of medical history, including school performance. Specific signs like myotonia and facial signs are explored, alongside the evolving landscape of genetic testing, advanced imaging techniques (MRI and ultrasound), and the potential of artificial intelligence in diagnostics. The speakers also touch on extra-muscular manifestations, expanding the understanding of these conditions.
Moderator: Gabriele Siciliano (Pisa, Italy)Guest: Antonio Toscano (Messina, Italy)Prof. Antonio Toscano is hosted by Prof. Gabriele Siciliano as he emphasizes the enduring significance of muscle biopsy in diagnosing neuromuscular disorders, particularly in cases of progressive muscle weakness. The episode stresses the need for a comprehensive diagnostic strategy, combining genetic testing with muscle biopsy, guided by clinical and imaging assessments. Overall, the episode underscores the continued importance of muscle biopsy for a thorough understanding of muscular dystrophies.
Comments
Download from Google Play
Download from App Store
United States